Ownership

Kevin Fitzgerald - Insider Trading & Ownership

Entity: Individual
Location: C/O Ovid Therapeutics Inc., 1460 Broadway, Suite 15044, New York, NY
Summary: The estimated net worth of Kevin Fitzgerald is at least $3.41M dollars as of March 5, 2025. Kevin Fitzgerald is the CSO & EVP, Head of Research of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $3.41M.
All Insider Reports: All Insider Reports

Ownership of Kevin Fitzgerald

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ALNY	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	$3.41M	-$8.32M	-70.9%	Mar 3, 2025
OVID	Ovid Therapeutics Inc.	Director				Dec 12, 2024

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Kevin Fitzgerald:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.